BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
See today's BioWorld
Home
» Other news to note for Sept. 9, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Sept. 9, 2020
Sep. 9, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agex, Ascletis, Asia Green, Atomwise, Berg, Biontech, Biopharma-Middle East and Africa, Caladrius, Chromadex, Cleave, Datavant, Eveliqure, Galmed, GC Pharma, Gigagen, Global Blood Therapeutics Inc., Ibio, Inveniai, Jazz, Johnson & Johnson, Lexicon, Lineage, Merck, Modulus, Monopar, Nkmax, Noden, Ocugen, Otsuka, Pathway, PDL, Pfizer, PNW, Presage, Prism, Redx, SXT, Takeda, Tersera, Tscan, Valneva, Versatope.
BioWorld
Briefs
Other news to note
Coronavirus